Drug Shortage Report for HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ

Last updated on 2020-01-03 History
Report ID 98073
Drug Identification Number 02209721
Brand name HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ
Common or Proper name Heparin Sodium in Dextrose
Company Name B. BRAUN MEDICAL INC
Market Status MARKETED
Active Ingredient(s) DEXTROSE HEPARIN SODIUM
Strength(s) 5G 10000UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 250mL
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-11-09
Actual start date
Estimated end date 2020-01-06
Actual end date 2019-12-19
Shortage status Resolved
Updated date 2020-01-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 824 TWELFTH AVENUE
BETHLEHEM, PENNSYLVANIA
UNITED STATES 18018
Company contact information Cindy Katsempris; cindy.katsempris@bbraunusa.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-01-03 French Compare
v6 2020-01-03 English Compare
v5 2019-12-10 French Compare
v4 2019-12-10 English Compare
v3 2019-11-10 English Compare
v2 2019-11-06 French Compare
v1 2019-11-06 English Compare

Showing 1 to 7 of 7